UK markets closed

Alibaba Health Information Technology Limited (ALBBY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
18.500.00 (0.00%)
As of 03:55PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close18.50
Open18.40
BidN/A x N/A
AskN/A x N/A
Day's range18.50 - 18.50
52-week range18.26 - 80.00
Volume1,870
Avg. volume2,456
Market cap12.476B
Beta (5Y monthly)0.38
PE ratio (TTM)N/A
EPS (TTM)-0.04
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Bloomberg

    China’s Tech Tycoons Pledge Allegiance to Xi’s Vision

    (Bloomberg) -- China’s embattled tech tycoons lined-up to pledge their support for President Xi Jinping’s “common prosperity” policy and market-roiling regulatory onslaught on the digital sector, at the country’s annual internet conference. Most Read from BloombergReshaped by Crisis, an ‘Anti-Biennial’ Reimagines ChicagoWall Street Titans Warn of the Next Big Risks for InvestorsAn Unapologetic Old Boys’ Network Is Costing Australia BillionsThis Is What Europe’s Green Future Looks LikeGhana’s Rec

  • Bloomberg

    China Tech Shares Stage Rebound After Five-Week Selloff

    (Bloomberg) -- Chinese technology stocks rallied in Hong Kong on Monday as bargain hunters pounced in the wake of the sector’s worst rout in months. The Hang Seng Tech Index closed 2.1% higher, following a near 11% slump last week that sent the gauge to the lowest level since its July 2020 inception on Friday. The index had dropped for five straight weeks, its longest losing streak since January 2019. The benchmark, which tracks the biggest technology stocks in China, has lost nearly 45% since a

  • Bloomberg

    Chinese Firm LinkDoc Said to Halt U.S. IPO After Crackdown

    (Bloomberg) -- LinkDoc Technology Ltd. has halted plans for a U.S. initial public offering, people familiar with the matter said, the first known company to pull out of a debut after China’s government cracked down on overseas listings.Market volatility has played a part in the postponement and the Beijing-based medical data company could revisit its listing plans when conditions improve, said one of the people, who asked not to be identified as the information is private.LinkDoc was slated to p